Wilmink, Michael

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wilmink, Michael's trades of Eupraxia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
364.83
Quantity 79,198 +2.7%
Value US$1,551,402
Transaction date
Purchase
Price
202.16
Quantity 98,746 -39.8%
Value US$4,240,215
Transaction date
Purchase
Price
243.48
Quantity 21,387 -31.5%
Value US$114,657
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-24 2025-09-24
B Purchase
79,198 +2.7%
364.83
US$1,551,402 		79,198 +2.7% 364.83 US$1,551,402
2024-09-11 2024-09-10
B Purchase
98,746 -39.8%
202.16
US$4,240,215 		98,746 -39.8% 202.16 US$4,240,215
2024-09-11 2024-09-04
B Purchase
21,387 -31.5%
243.48
US$114,657 		21,387 -31.5% 243.48 US$114,657
2024-06-17 2024-06-17
B Purchase
1,100 +0.5%
2.66
US$2,926 		1,100 +0.5% 2.66 US$2,926
2023-08-20 2023-08-18
B Purchase
2,857 +1.3%
7.00
CA$19,999 		2,857 +1.3% 7.00 CA$19,999
2021-11-19 2021-11-15
B Purchase
22,014
1.81
CA$39,801 		22,014 1.81 CA$39,801